Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Glaser

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Pediatric Dermatology|June 11, 2015
A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary HyperhidrosisDee Anna Glaser, David M Pariser, Adelaide A Hebert, et al.
Aesthetic Surgery Journal|March 6, 2018
Safety and Effectiveness of Repeat Treatment With VYC-15L for Lip and Perioral Enhancement: Results From a Prospective Multicenter StudyAlexander Rivkin, Susan H Weinkle, Bhushan Hardas, et al.
Pediatric Dermatology|November 20, 2018
Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trialsAdelaide A Hebert, Dee Anna Glaser, Lawrence Green, et al.
Multiple Sclerosis and Related Disorders|December 18, 2022
Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in SwedenFitsum Sebsibe Teni, Alejandra Machado, Chantelle Murley, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 19, 2019
A Double-Blind, Placebo-Controlled, Phase 3b Study of ATX-101 for Reduction of Mild or Extreme Submental FatRichard G Glogau, Dee Anna Glaser, Valerie D Callender, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2018
Predicting risk of secondary progression in multiple sclerosis: A nomogramAli Manouchehrinia, Feng Zhu, Daniela Piani-Meier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 4, 2017
Age Related Multiple Sclerosis Severity Score: Disability ranked by ageAli Manouchehrinia, Helga Westerlind, Elaine Kingwell, et al.
Journal of the American Academy of Dermatology|July 14, 2018
Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trialsDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Neurogenetics|October 16, 2008
Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutationLena Skoglund, RoseMarie Brundin, Tommie Olofsson, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 1, 2012
A randomized, blinded clinical evaluation of a novel microwave device for treating axillary hyperhidrosis: the dermatologic reduction in underarm perspiration studyDee Anna Glaser, William P Coleman, Larry K Fan, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Pediatric Dermatology|June 11, 2015
A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary HyperhidrosisDee Anna Glaser, David M Pariser, Adelaide A Hebert, et al.
Aesthetic Surgery Journal|March 6, 2018
Safety and Effectiveness of Repeat Treatment With VYC-15L for Lip and Perioral Enhancement: Results From a Prospective Multicenter StudyAlexander Rivkin, Susan H Weinkle, Bhushan Hardas, et al.
Pediatric Dermatology|November 20, 2018
Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trialsAdelaide A Hebert, Dee Anna Glaser, Lawrence Green, et al.
Multiple Sclerosis and Related Disorders|December 18, 2022
Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in SwedenFitsum Sebsibe Teni, Alejandra Machado, Chantelle Murley, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 19, 2019
A Double-Blind, Placebo-Controlled, Phase 3b Study of ATX-101 for Reduction of Mild or Extreme Submental FatRichard G Glogau, Dee Anna Glaser, Valerie D Callender, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2018
Predicting risk of secondary progression in multiple sclerosis: A nomogramAli Manouchehrinia, Feng Zhu, Daniela Piani-Meier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 4, 2017
Age Related Multiple Sclerosis Severity Score: Disability ranked by ageAli Manouchehrinia, Helga Westerlind, Elaine Kingwell, et al.
Journal of the American Academy of Dermatology|July 14, 2018
Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trialsDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Neurogenetics|October 16, 2008
Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutationLena Skoglund, RoseMarie Brundin, Tommie Olofsson, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 1, 2012
A randomized, blinded clinical evaluation of a novel microwave device for treating axillary hyperhidrosis: the dermatologic reduction in underarm perspiration studyDee Anna Glaser, William P Coleman, Larry K Fan, et al.
Pageof 10